The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
Role of the Microenvironment in the Pathogenesis and Treatment of Hepatocellular Carcinoma
Open accessAbstract
Hepatocellular carcinoma (HCC) is the most common primary liver tumor and the third cause of cancer-related death worldwide, and its incidence is increasing. Despite the significant improvement in HCC management in the last 30 years, there are no effective chemoprevention strategies, and only 1 systemic therapy has been approved for patients with advanced tumors. This drug, sorafenib, acts on tumor cells and the stroma. HCC develops from chronically damaged tissue that contains large amounts of inflammation and fibrosis, which also promote tumor progression and resistance to therapy. Increasing our understanding of how stromal components interact with cancer cells and the signaling pathways involved could identify new therapeutic and chemopreventive targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Self-citationBevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib
Kudo, M. (2017) · Liver Cancer · doi:10.1159/000462153 · Cited by 5,936
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690
Llovet, J. M., Burroughs, A., & Bruix, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14964-1 · Cited by 3,608
Self-citationOlive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
The extracellular matrix: A dynamic niche in cancer progression
Lu, P., Weaver, V. M., & Werb, Z. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201102147 · Cited by 3,024
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
Self-citationNF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
Collagen reorganization at the tumor-stromal interface facilitates local invasion
Provenzano, P. P., Eliceiri, K. W., Campbell, J. M., Inman, D. R., White, J. G., & Keely, P. J. (2006) · BMC Medicine · doi:10.1186/1741-7015-4-38 · Cited by 1,804
Friends or foes — bipolar effects of the tumour stroma in cancer
Mueller, M. M., & Fusenig, N. E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1477 · Cited by 1,765
DeNardo, D. G., Brennan, D. J., Rexhepaj, E., Ruffell, B., Shiao, S. L., Madden, S. F., Gallagher, W. M., Wadhwani, N., Keil, S. D., Junaid, S. A., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-10-0028 · Cited by 1,715
Openings Between Defective Endothelial Cells Explain Tumor Vessel Leakiness
Hashizume, H., Baluk, P., Morikawa, S., McLean, J. W., Thurston, G., Roberge, S., Jain, R. K., & McDonald, D. M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65006-7 · Cited by 1,689
The protein kinase B/Akt signalling pathway in human malignancy
Nicholson, K. M., & Anderson, N. G. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00271-6 · Cited by 1,639
Wilhelm, S. M., Adnane, L., Newell, P., Villanueva, A., Llovet, J. M., & Lynch, M. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0013 · Cited by 1,459
Self-citationGuichard, C., Amaddeo, G., Imbeaud, S., Ladeiro, Y., Pelletier, L., Maad, I. B., Calderaro, J., Bioulac-Sage, P., Letexier, M., Degos, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2256 · Cited by 1,453
Targeting MET in cancer: rationale and progress
Gherardi, E., Birchmeier, W., Birchmeier, C., & Woude, G. V. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3205 · Cited by 1,423
TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia
Bhowmick, N. A., Chytil, A., Plieth, D., Gorska, A. E., Dumont, N., Shappell, S., Washington, M. K., Neilson, E. G., & Moses, H. L. (2004) · Science · doi:10.1126/science.1090922 · Cited by 1,401
Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
Dapito, D. H., Mencin, A., Gwak, G.-Y., Pradere, J.-P., Jang, M.-K., Mederacke, I., Caviglia, J. M., Khiabanian, H., Adeyemi, A., Bataller, R., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.007 · Cited by 1,346
NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma
Luedde, T., & Schwabe, R. F. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.213 · Cited by 1,345
Molecular characterization of the tumor microenvironment in breast cancer
Allinen, M., Beroukhim, R., Cai, L., Brennan, C., Lahti-Domenici, J., Huang, H., Porter, D., Hu, M., Chin, L., Richardson, A., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.010 · Cited by 1,299
Gene expression in fixed tissues and outcome in hepatocellular carcinoma
Hoshida, Y., Villanueva, A., Kobayashi, M., Peix, J., Chiang, D. Y., Camargo, A., Gupta, S., Moore, J., Wrobel, M. J., Lerner, J., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804525 · Cited by 1,286
Self-citationTranscriptome classification of HCC is related to gene alterations and to new therapeutic targets
Boyault, S., Rickman, D. S., de Reyniès, A., Balabaud, C., Rebouissou, S., Jeannot, E., Hérault, A., Saric, J., Belghiti, J., Franco, D., et al. (2007) · Hepatology · doi:10.1002/hep.21467 · Cited by 1,258
Hoshida, Y., Nijman, S. M. B., Kobayashi, M., Chan, J. A., Brunet, J.-P., Chiang, D. Y., Villanueva, A., Newell, P., Ikeda, K., Hashimoto, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1089 · Cited by 1,238
Self-citationIdentification and Characterization of Tumorigenic Liver Cancer Stem/Progenitor Cells
Ma, S., Chan, K., Hu, L., Lee, T. K., Wo, J. Y., Ng, I. O., Zheng, B., & Guan, X. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.025 · Cited by 1,192
Significance of CD90+ Cancer Stem Cells in Human Liver Cancer
Yang, Z. F., Ho, D. W., Ng, M. N., Lau, C. K., Yu, W. C., Ngai, P., Chu, P. W. K., Lam, C. T., Poon, R. T. P., & Fan, S. T. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.013 · Cited by 1,188
Trophic macrophages in development and disease
Pollard, J. W. (2009) · Nature Reviews Immunology · doi:10.1038/nri2528 · Cited by 1,178
Maeda, S., Kamata, H., Luo, J.-L., Leffert, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2005.04.014 · Cited by 1,164
Yamashita, T., Ji, J., Budhu, A., Forgues, M., Yang, W., Wang, H., Jia, H., Ye, Q., Qin, L., Wauthier, E., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.004 · Cited by 1,149
Oxygen Sensing, Homeostasis, and Disease
Semenza, G. L. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011165 · Cited by 993
A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells
Lee, J.-S., Heo, J., Libbrecht, L., Chu, I.-S., Kaposi-Novak, P., Calvisi, D. F., Mikaelyan, A., Roberts, L. R., Demetris, A. J., Sun, Z., et al. (2006) · Nature Medicine · doi:10.1038/nm1377 · Cited by 953
Intravital imaging of cell movement in tumours
Condeelis, J., & Segall, J. E. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1231 · Cited by 929
Fu, J., Xu, D., Liu, Z., Shi, M., Zhao, P., Fu, B., Zhang, Z., Yang, H., Zhang, H., Zhou, C., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.102 · Cited by 897
Roussos, E. T., Condeelis, J. S., & Patsialou, A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3078 · Cited by 896
Resection and Liver Transplantation for Hepatocellular Carcinoma
Llovet, J. M., Schwartz, M., & Mazzaferro, V. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-871198 · Cited by 879
Self-citationMYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer
Shachaf, C. M., Kopelman, A. M., Arvanitis, C., Karlsson, Å., Beer, S., Mandl, S., Bachmann, M. H., Borowsky, A. D., Ruebner, B., Cardiff, R. D., et al. (2004) · Nature · doi:10.1038/nature03043 · Cited by 874
Barry-Hamilton, V., Spangler, R., Marshall, D., McCauley, S., Rodriguez, H. M., Oyasu, M., Mikels, A., Vaysberg, M., Ghermazien, H., Wai, C., et al. (2010) · Nature Medicine · doi:10.1038/nm.2208 · Cited by 870
Budhu, A., Forgues, M., Ye, Q.-H., Jia, H.-L., He, P., Zanetti, K. A., Kammula, U. S., Chen, Y., Qin, L.-X., Tang, Z.-Y., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.06.016 · Cited by 846
HIF and c-Myc: Sibling Rivals for Control of Cancer Cell Metabolism and Proliferation
Gordan, J. D., Thompson, C. B., & Simon, M. C. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.006 · Cited by 803
Stromal Fibroblasts in Cancer: A Novel Tumor-Promoting Cell Type
Orimo, A., & Weinberg, R. A. (2006) · Cell Cycle · doi:10.4161/cc.5.15.3112 · Cited by 799
Sethi, T., Rintoul, R. C., Moore, S. M., MacKinnon, A. C., Salter, D., Choo, C., Chilvers, E. R., Dransfield, I., Donnelly, S. C., Strieter, R., et al. (1999) · Nature Medicine · doi:10.1038/9511 · Cited by 739
Serum levels of cytokines in chronic liver diseases
Tilg, H., Wilmer, A., Vogel, W., Herold, M., Nölchen, B., Judmaier, G., & Huber, C. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91122-k · Cited by 739
Schrader, J., Gordon-Walker, T. T., Aucott, R. L., van Deemter, M., Quaas, A., Walsh, S., Benten, D., Forbes, S. J., Wells, R. G., & Iredale, J. P. (2011) · Hepatology · doi:10.1002/hep.24108 · Cited by 720
Focal Gains of VEGFA and Molecular Classification of Hepatocellular Carcinoma
Chiang, D. Y., Villanueva, A., Hoshida, Y., Peix, J., Newell, P., Minguez, B., LeBlanc, A. C., Donovan, D. J., Thung, S. N., Solé, M., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0742 · Cited by 719
Self-citationMaximizing mouse cancer models
Frese, K. K., & Tuveson, D. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2192 · Cited by 717
EpCAM and α-Fetoprotein Expression Defines Novel Prognostic Subtypes of Hepatocellular Carcinoma
Yamashita, T., Forgues, M., Wang, W., Kim, J. W., Ye, Q., Jia, H., Budhu, A., Zanetti, K. A., Chen, Y., Qin, L.-X., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6013 · Cited by 717
Dual Roles of Immune Cells and Their Factors in Cancer Development and Progression
Zamarron, B. F., & Chen, W. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.651 · Cited by 681
Angiogenesis-Independent Endothelial Protection of Liver: Role of VEGFR-1
LeCouter, J., Moritz, D. R., Li, B., Phillips, G. L., Liang, X. H., Gerber, H.-P., Hillan, K. J., & Ferrara, N. (2003) · Science · doi:10.1126/science.1079562 · Cited by 679
Evolution of the cancer genome
Yates, L. R., & Campbell, P. J. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3317 · Cited by 640
A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer
Farmer, P., Bonnefoi, H., Anderle, P., Cameron, D., Wirapati, P., Becette, V., André, S., Piccart, M., Campone, M., Brain, E., et al. (2009) · Nature Medicine · doi:10.1038/nm.1908 · Cited by 623
Lee, T. K. W., Castilho, A., Cheung, V. C. H., Tang, K. H., Ma, S., & Ng, I. O. L. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.06.005 · Cited by 586
HCC and angiogenesis: possible targets and future directions
Zhu, A. X., Duda, D. G., Sahani, D. V., & Jain, R. K. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.30 · Cited by 564
Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma
Llovet, J. M., Peña, C. E. A., Lathia, C. D., Shan, M., Meinhardt, G., & Bruix, J. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2175 · Cited by 559
Self-citationZhang, J.-P., Yan, J., Xu, J., Pang, X.-H., Chen, M.-S., Li, L., Wu, C., Li, S.-P., & Zheng, L. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.033 · Cited by 535
Sergio, A., Cristofori, C., Cardin, R., Pivetta, G., Ragazzi, R., Baldan, A., Girardi, L., Cillo, U., Burra, P., Giacomin, A., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01712.x · Cited by 512
Jiang, J., Gusev, Y., Aderca, I., Mettler, T. A., Nagorney, D. M., Brackett, D. J., Roberts, L. R., & Schmittgen, T. D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0523 · Cited by 511
Pten in stromal fibroblasts suppresses mammary epithelial tumours
Trimboli, A. J., Cantemir-Stone, C. Z., Li, F., Wallace, J. A., Merchant, A., Creasap, N., Thompson, J. C., Caserta, E., Wang, H., Chong, J.-L., et al. (2009) · Nature · doi:10.1038/nature08486 · Cited by 500
Targeted Therapies for Hepatocellular Carcinoma
Villanueva, A., & Llovet, J. M. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.03.006 · Cited by 449
Self-citationFibrosis-dependent mechanisms of hepatocarcinogenesis
Zhang, D. Y., & Friedman, S. L. (2012) · Hepatology · doi:10.1002/hep.25670 · Cited by 444
Self-citationHe, G., Yu, G.-Y., Temkin, V., Ogata, H., Kuntzen, C., Sakurai, T., Sieghart, W., Peck-Radosavljevic, M., Leffert, H. L., & Karin, M. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.048 · Cited by 427
Kryczek, I., Lange, A., Mottram, P., Alvarez, X., Cheng, P., Hogan, M., Moons, L., Wei, S., Zou, L., Machelon, V., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.465.65.2 · Cited by 421
Th, M., van Nieuwkerk, C. M., Dingemans, K. P., Smit, J. J., Schinkel, A. H., Notenboom, R. G. E., Weerman, M. A. V. D. B., VERKRUISEN, R. P., Groen, A. K., & Elferink, R. P. J. O. (1994) · PubMed · Cited by 403
Kaposi-Novak, P. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27236 · Cited by 398
Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology
Pello, O. M., De Pizzol, M., Mirolo, M., Soucek, L., Zammataro, L., Amabile, A., Doni, A., Nebuloni, M., Swigart, L. B., Evan, G. I., et al. (2012) · Blood · doi:10.1182/blood-2011-02-339911 · Cited by 386
A Lymphotoxin-Driven Pathway to Hepatocellular Carcinoma
Haybaeck, J., Zeller, N., Wolf, M. J., Weber, A., Wagner, U., Kurrer, M. O., Bremer, J., Iezzi, G., Graf, R., Clavien, P.-A., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.08.021 · Cited by 383
Zhang, W., Zhu, X.-D., Sun, H.-C., Xiong, Y.-Q., Zhuang, P.-Y., Xu, H.-X., Kong, L.-Q., Wang, L., Wu, W.-Z., & Tang, Z.-Y. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2904 · Cited by 374
Experimental mouse models for hepatocellular carcinoma research
Heindryckx, F., Colle, I., & Van Vlierberghe, H. (2009) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2009.00656.x · Cited by 367
The role of the EGFR signaling in tumor microenvironment
De Luca, A., Carotenuto, A., Rachiglio, A., Gallo, M., Maiello, M. R., Aldinucci, D., Pinto, A., & Normanno, N. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21260 · Cited by 359
Chew, V., Chen, J., Lee, D., Loh, E., Lee, J., Lim, K. H., Weber, A., Slankamenac, K., Poon, R. T. P., Yang, H., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300509 · Cited by 359
Lichtenberger, B. M., Tan, P. K., Niederleithner, H., Ferrara, N., Petzelbauer, P., & Sibilia, M. (2010) · Cell · doi:10.1016/j.cell.2009.12.046 · Cited by 358
Yu, L.-X., Yan, H.-X., Liu, Q., Yang, W., Wu, H.-P., Dong, W., Tang, L., Lin, Y., He, Y.-Q., Zou, S.-S., et al. (2010) · Hepatology · doi:10.1002/hep.23845 · Cited by 349
Shi, Y.-H., Ding, Z.-B., Zhou, J., Hui, B., Shi, G.-M., Ke, A.-W., Wang, X.-Y., Dai, Z., Peng, Y.-F., Gu, C.-Y., et al. (2011) · Autophagy · doi:10.4161/auto.7.10.16818 · Cited by 344
Schiffer, E., Housset, C., Cacheux, W., Wendum, D., Desbois‐Mouthon, C., Rey, C., Clergue, F., Poupon, R., Barbu, V., & Rosmorduc, O. (2005) · Hepatology · doi:10.1002/hep.20538 · Cited by 340
Inflammation and the development of pancreatic cancer
Farrow, B., & Evers, B. M. (2002) · Surgical Oncology · doi:10.1016/s0960-7404(02)00015-4 · Cited by 338
Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma
Campbell, J. S., Hughes, S. D., Gilbertson, D. G., Palmer, T. E., Holdren, M. S., Haran, A. C., Odell, M. M., Bauer, R. L., Ren, H.-P., Haugen, H. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409722102 · Cited by 333
Liver stem cells and hepatocellular carcinoma†
Mishra, L., Banker, T., Murray, J., Byers, S., Thenappan, A., He, A. R., Shetty, K., Johnson, L., & Reddy, E. P. (2009) · Hepatology · doi:10.1002/hep.22704 · Cited by 333
Seitz, H. K., & Stickel, F. (2006) · Biological Chemistry · doi:10.1515/bc.2006.047 · Cited by 325
The role of cytokines in hepatocellular carcinoma
Budhu, A., & Wang, X. W. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0506297 · Cited by 319
McMillin, D. W., Delmore, J., Weisberg, E., Negri, J. M., Geer, D. C., Klippel, S., Mitsiades, N., Schlossman, R. L., Munshi, N. C., Kung, A. L., et al. (2010) · Nature Medicine · doi:10.1038/nm.2112 · Cited by 315
Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3
Jiang, R., Tan, Z., Deng, L., Chen, Y., Xia, Y., Gao, Y., Wang, X., & Sun, B. (2011) · Hepatology · doi:10.1002/hep.24486 · Cited by 310
Oxidative Stress, Tumor Microenvironment, and Metabolic Reprogramming: A Diabolic Liaison
Fiaschi, T., & Chiarugi, P. (2012) · International Journal of Cell Biology · doi:10.1155/2012/762825 · Cited by 302
Breast-Cancer Stromal Cells with TP53 Mutations and Nodal Metastases
Patocs, A., Zhang, L., Xu, Y., Weber, F., Caldes, T., Mutter, G. L., Platzer, P., & Eng, C. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071825 · Cited by 297
Mejias, M., Garcia-Pras, E., Tiani, C., Miquel, R., Bosch, J., & Fernandez, M. (2009) · Hepatology · doi:10.1002/hep.22758 · Cited by 293
Therapeutic targeting of a stem cell niche
Adams, G. B., Martin, R. P., Alley, I. R., Chabner, K. T., Cohen, K. S., Calvi, L. M., Kronenberg, H. M., & Scadden, D. T. (2007) · Nature Biotechnology · doi:10.1038/nbt1281 · Cited by 289
Zhang, H.-L., Yu, L.-X., Yang, W., Tang, L., Lin, Y., Wu, H., Zhai, B., Tan, Y.-X., Shan, L., Liu, Q., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.06.011 · Cited by 281
Angiogenesis in chronic liver disease and its complications: Angiogenesis in CLD
Coulon, S., Heindryckx, F., Geerts, A., Van Steenkiste, C., Colle, I., & Van Vlierberghe, H. (2011) · Liver International · doi:10.1111/j.1478-3231.2010.02369.x · Cited by 276
Deregulated MYC expression induces dependence upon AMPK-related kinase 5
Liu, L., Ulbrich, J., Müller, J., Wüstefeld, T., Aeberhard, L., Kress, T. R., Muthalagu, N., Rycak, L., Rudalska, R., Moll, R., et al. (2012) · Nature · doi:10.1038/nature10927 · Cited by 276
Ding, Z.-B., Shi, Y.-H., Zhou, J., Qiu, S.-J., Xu, Y., Dai, Z., Shi, G.-M., Wang, X.-Y., Ke, A.-W., Wu, B., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1573 · Cited by 273
Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines.
Bronzert, D. A., Pantazis, P., Antoniades, H. N., Kasid, A., Davidson, N., Dickson, R. B., & Lippman, M. E. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.16.5763 · Cited by 266
Ding, T., Xu, J., Wang, F., Shi, M., Zhang, Y., Li, S.-P., & Zheng, L. (2009) · Human Pathology · doi:10.1016/j.humpath.2008.08.011 · Cited by 232
Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma
Wu, X., Xie, G., & Chen, D. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04997.x · Cited by 212
Clinical Implications of Cancer Stem Cell Biology in Hepatocellular Carcinoma
Ji, J., & Wang, X. W. (2012) · Seminars in Oncology · doi:10.1053/j.seminoncol.2012.05.011 · Cited by 210
Tanabe, K. K., Lemoine, A., Finkelstein, D. M., Kawasaki, H., Fujii, T., Chung, R. T., Lauwers, G. Y., Kulu, Y., Muzikansky, A., Kuruppu, D., et al. (2008) · JAMA · doi:10.1001/jama.2007.65 · Cited by 207
Lisanti, M. P., Martinez-Outschoorn, U. E., Chiavarina, B., Pavlides, S., Whitaker-Menezes, D., Tsirigos, A., Witkiewicz, A. K., Lin, Z., Balliet, R. M., Howell, A., et al. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.6.13370 · Cited by 199
Ren, Y., Poon, R. T. P., Tsui, H., Chen, W.-H., Li, Z., Lau, C. P.-Y., Yu, W., & Fan, S.-T. (2003) · PubMed · Cited by 192
Clinical role of MMP‐2/TIMP‐2 imbalance in hepatocellular carcinoma
Giannelli, G., Bergamini, C., Marinosci, F., Fransvea, E., Quaranta, M., Lupo, L., Schiraldi, O., & Antonaci, S. (2002) · International Journal of Cancer · doi:10.1002/ijc.1635 · Cited by 187
Beckebaum, S., Zhang, X., Chen, X., Yu, Z., Frilling, A., Dworacki, G., Grosse-Wilde, H., Broelsch, C. E., Gerken, G., & Cicinnati, V. R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0872 · Cited by 181
Anson, M., Crain-Denoyelle, A.-M., Baud, V., Chereau, F., Gougelet, A., Terris, B., Yamagoe, S., Colnot, S., Viguier, M., Perret, C., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci43937 · Cited by 179
Endogenous Myc maintains the tumor microenvironment
Sodir, N. M., Swigart, L. B., Karnezis, A. N., Hanahan, D., Evan, G. I., & Soucek, L. (2011) · Genes & Development · doi:10.1101/gad.2038411 · Cited by 179
Neaud, V, Faouzi, S., Guirouilh, J., Le Bail, B., Balabaud, C., Bioulac-Sage, P., & Rosenbaum, J. (1997) · Hepatology · doi:10.1002/hep.510260612 · Cited by 167
Mitsiades, C. S., Mitsiades, N., Munshi, N. C., & Anderson, K. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.020 · Cited by 166
Migneco, G., Whitaker-Menezes, D., Chiavarina, B., Castello-Cros, R., Pavlides, S., Pestell, R. G., Fatatis, A., Flomenberg, N., Tsirigos, A., Howell, A., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.12.11989 · Cited by 153
HAb18G/CD147 Functions in Invasion and Metastasis of Hepatocellular Carcinoma
Xu, J., Xu, H., Zhang, Q., Song, F., Jiang, J., Yang, X.-M., Mi, L., Wen, N., Tian, R., Wang, L., et al. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0286 · Cited by 146
Role of the microenvironment in hepatocellular carcinoma development and progression
Wu, S., Ma, Y., Fang, Y., Liu, L., Fu, D., & Shen, X. (2011) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.06.010 · Cited by 145
Bollyky, P. L., Wu, R. P., Falk, B. A., Lord, J. D., Long, S. A., Preisinger, A., Teng, B. J., Holt, G. E., Standifer, N. E., Braun, K. R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017360108 · Cited by 145
Sutton, A., Friand, V., Brulé, S., Chaigneau, T., Ziol, M., Sainte‐Catherine, O., Poiré, A., Saffar, L., Kraemer, M., Vassy, J., et al. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0103 · Cited by 142
Gong, K., Chen, C., Zhan, Y., Chen, Y., Huang, Z., & Li, W. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.370585 · Cited by 141
Dayyeh, B. K. A., YANG, M. H., Fuchs, B. C., Karl, D. L., Yamada, S., Sninsky, J. J., OʼBrien, T. R., Dienstag, J. L., Tanabe, K. K., & Chung, R. T. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.03.045 · Cited by 141
Tao, Y., Ruan, J., Yeh, S., Lu, X., Wang, Y., Zhai, W., Cai, J., Ling, S., Gong, Q., Chong, Z., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108715108 · Cited by 134
Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma
Abou-Shady, M. A., Baer, H. U., Friess, H., Berberat, P. O., Zimmermann, A., Graber, H. U., Gold, L. I., Korc, M., & Büchler, M. W. (1999) · The American Journal of Surgery · doi:10.1016/s0002-9610(99)00012-4 · Cited by 133
Yang, C., Zeisberg, M., Lively, J. C., Nyberg, P., Afdhal, N. H., & Kalluri, R. (2003) · PubMed · Cited by 130
Hepatocellular carcinoma: insight from animal models
Li, Y., Tang, Z., & Hou, J. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.196 · Cited by 129
New Strategies in Hepatocellular Carcinoma: Genomic Prognostic Markers
Villanueva, A., Hoshida, Y., Toffanin, S., Lachenmayer, A., Alsinet, C., Savić, R., Cornellà, H., & Llovet, J. M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1811 · Cited by 129
Self-citationMazzocca, A., Fransvea, E., Lavezzari, G., Antonaci, S., & Giannelli, G. (2009) · Hepatology · doi:10.1002/hep.23118 · Cited by 127
Molecular Mechanisms of Liver Carcinogenesis in the Mdr2-Knockout Mice
Katzenellenbogen, M., Mizrahi, L., Pappo, O., Klopstock, N., Olam, D., Jacob‐Hirsch, J., Amariglio, N., Rechavi, G., Domany, E., Galun, E., et al. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0172 · Cited by 115
Recent developments in the regulation of the angiogenic switch by cellular stress factors in tumors
North, S., Moenner, M., & Bikfalvi, A. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.08.007 · Cited by 113
Second-Line Therapies in Hepatocellular Carcinoma: Emergence of Resistance to Sorafenib
Villanueva, A., & Llovet, J. M. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0151 · Cited by 105
Self-citationShen, X., Li, N., Li, H., Zhang, T., Wang, F., & Li, Q. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0833-8 · Cited by 104
Yoshiji, H., Kuriyama, S., Noguchi, R., Yoshii, J., Ikenaka, Y., Yanase, K., Namisaki, T., Kitade, M., Uemura, M., Masaki, T., et al. (2005) · Gut · doi:10.1136/gut.2005.067900 · Cited by 94
Okamoto, M., Utsunomiya, T., Wakiyama, S., Hashimoto, M., Fukuzawa, K., Ezaki, T., Hanai, T., Inoue, H., & Mori, M. (2006) · Annals of Surgical Oncology · doi:10.1245/aso.2006.07.018 · Cited by 91
Mouse Models of Hepatocellular Carcinoma
Fausto, N., & Campbell, J. S. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1247135 · Cited by 91
Chung, J. S., Park, S., Park, S. H., Park, E., Cha, P.-H., Kim, B., Chung, Y. M., Woo, S., Han, C. J., Kim, S. J., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.038 · Cited by 90
Cancer stem cells and hepatocellular carcinoma
Yao, Z., & Mishra, L. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.18.9843 · Cited by 86
The autophagy conundrum in cancer: influence of tumorigenic metabolic reprogramming
Eng, C. H., & Abraham, R. T. (2011) · Oncogene · doi:10.1038/onc.2011.220 · Cited by 85
Liu, H., Pan, Z., Li, A., Fu, S., Lei, Y., Sun, H., Wu, M., & Zhou, W. (2008) · Cellular and Molecular Immunology · doi:10.1038/cmi.2008.46 · Cited by 85
Zhu, A. X. (2012) · Seminars in Oncology · doi:10.1053/j.seminoncol.2012.05.014 · Cited by 82
Baek, H. J., Lim, S., Kitisin, K., Jogunoori, W. S., Tang, Y., Marshall, M. B., Mishra, B., Kim, T. H., Cho, K. H., Kim, S. S., et al. (2008) · Hepatology · doi:10.1002/hep.22460 · Cited by 73
Hewitt, R. E., Powe, D. G., Morrell, K., Balley, E., LEACH, I. H., Ellis, I. O., & Turner, D. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.37 · Cited by 69
Stem Cells in Hepatocarcinogenesis: Evidence from Genomic Data
Marquardt, J. U., & Thorgeirsson, S. S. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1247130 · Cited by 66
Inflammatory Immune Responses in Tumor Microenvironment and Metastasis of Hepatocellular Carcinoma
Qin, L. (2012) · Cancer Microenvironment · doi:10.1007/s12307-012-0111-1 · Cited by 66
Li, W. S., Gomez, E., & Zhang, Z. M. (2007) · PubMed · Cited by 60
Amann, T., Bataille, F., Spruß, T., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090356 · Cited by 59
Wang, Y., Wang, W., Wang, L., Wang, X., & Xia, J. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01337.x · Cited by 58
Zhou, H., Huang, H., Shi, J., Zhao, Y., Dong, Q., Jia, H., Liu, Y., Ye, Q., Sun, H., Zhu, X., et al. (2010) · Gut · doi:10.1136/gut.2010.218404 · Cited by 56
Chemokine receptor CCR6 as a prognostic factor after hepatic resection for hepatocellular carcinoma
Uchida, H., Iwashita, Y., Sasaki, A., Shibata, K., Matsumoto, T., Ohta, M., & Kitano, S. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.04157.x · Cited by 48
The hepatitis B viral X protein activates NF‐κB signaling pathway through the up‐regulation of TBK1
Kim, H., Lee, S. H., & Jung, G. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.11.091 · Cited by 46
Expression of interleukin-18, interferon-γ and interleukin-10 in hepatocellular carcinoma
Chia, C. S., Ban, K., Ithnin, H., Singh, H., Krishnan, R., Mokhtar, S., Malihan, N., & Seow, H. F. (2002) · Immunology Letters · doi:10.1016/s0165-2478(02)00176-1 · Cited by 40
Modulation of tumor associated macrophages in solid tumors
Lucas, T., Abraham, D., & Aharinejad, S. (2008) · Frontiers in bioscience · doi:10.2741/3101 · Cited by 31
Costimulation by Extracellular Matrix Proteins Determines the Response to TCR Ligation
Adler, B., Ashkar, S., Cantor, H., & Weber, G. F. (2001) · Cellular Immunology · doi:10.1006/cimm.2001.1800 · Cited by 31
Cited by
Llovet, J. M., Zucman-Rossi, J., Pikarsky, E., Sangro, B., Schwartz, M., Sherman, M., & Gores, G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.18 · Cited by 2,531
Self-citationLiver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis
Sia, D., Villanueva, A., Friedman, S. L., & Llovet, J. M. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.11.048 · Cited by 1,153
Self-citationYau, T., Park, J.-W., Finn, R. S., Cheng, A.-L., Mathurin, P., Edeline, J., Kudo, M., Harding, J. J., Merle, P., Rosmorduc, O., et al. (2022) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00604-5 · Cited by 1,106
The immunology of hepatocellular carcinoma
Ringelhan, M., Pfister, D., O’Connor, T., Pikarsky, E., & Heikenwalder, M. (2018) · Nature Immunology · doi:10.1038/s41590-018-0044-z · Cited by 1,076
Zhou, S.-L., Zhou, Z.-J., Hu, Z.-Q., Huang, X.-W., Wang, Z., Chen, E.-B., Fan, J., Cao, Y., Dai, Z., & Zhou, J. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.040 · Cited by 852
Metadata
- Authors
- Hernandez–Gea, V., Toffanin, S., Friedman, S. L., & Llovet, J. M.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2013-03
- Volume
- 144
- Issue
- 3
- Pages
- 512-527
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W1963920328
- Cited by
- 722
- References
- 147
- FWCI
- 33.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.